Aktis Oncology, Inc. (AKTS)

Aktis Oncology Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2024	Dec 31, 2023
Debt / Equity Ratio	-0.09	-0.14	-0.29
Debt / EBITDA Ratio	-0.16	-0.22	-0.37
Debt / FCF Ratio	-0.17	1.01	-0.40
Quick Ratio	9.15	15.79	15.69
Return on Equity (ROE)	45.81%	50.09%	61.85%
Return on Assets (ROA)	-	-13.48%	-23.41%
Return on Capital (ROIC)	60.52%	68.67%	105.74%
Return on Capital Employed (ROCE)	271.23%	-16.95%	-29.30%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).